The Intra Abdominal Pressure Measurement Devices Market, estimated at USD 144.2 Mn in 2025, is expected to exhibit a CAGR of 16.1% and reach USD 410.0 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
To bring patient-centered, high-quality care to more communities, by the various market players are engaged in adoption of growth strategies which is expected to offer significant growth opportunities for players in the global Intra Abdominal Pressure Measurement Devices Market. For instance, Intra bladder pressure monitoring is considered the method of choice for intra abdominal pressure monitoring. Urinary Foley catheter is a device that is compatible with the Clarity Renal Monitoring System Critical Monitoring System which are manufactured by Renal Sense, an Israel based medical device company. This kit helps to measure urinary output and transmits real-time data with great precision.
Global Intra Abdominal Pressure Measurement Devices Market– Impact of Coronavirus (COVID-19) Pandemic
Since the outbreak of the COVID-19 epidemic in December 2025, the disease has spread to more than 100 countries worldwide and has been declared a public health emergency by the World Health Organization. As of September 3, 2025, the emergence of the coronavirus (COVID-19) had claimed more than 25.6 million lives worldwide, according to a report by the World Health Organization. The demand for intra-abdominal pressure devices increased significantly during the coronavirus pandemic, where patients with COVID-19 developed severe symptoms that led to death, intra-abdominal pressure devices were used to monitor vital signs. In addition, several health regulatory agencies have issued guidelines for patients requiring intensive care during the COVID-19 pandemic. For instance, On March 20, 2025, the National Institute for Clinical Excellence (NICE) published guidance on maximizing the safety of patients in intensive care during the COVID-19 pandemic, while protecting staff from infection.